Skip to content
10-Q

Quarterly Report

ORCHARD THERAPEUTICS PLC

0000950170-23-062428

← back to feed
Filed
Nov 13, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 9, 2023 227.61M sh
Shares Diluted Q3 2023 · Sep 30, 2023 228.39B sh
Shares Diluted Q3 2023 · Sep 30, 2023 186.81B sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 128.13B sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 127.9B sh
Capex Q3 2023 · Sep 30, 2023 $609K
Capex Q3 2023 · Sep 30, 2022 $6.03M
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$81.23M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$63.9M
Long Term Debt Q3 2023 · Sep 30, 2023 $16.16M
Long Term Debt Q3 2023 · Dec 31, 2022 $22.99M
Short Term Debt Q3 2023 · Sep 30, 2023 $9.43M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $23.47M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $68.42M
Stockholders Equity Q3 2023 · Sep 30, 2023 $80.26M
Stockholders Equity Q3 2023 · Jun 30, 2023 $109.05M
Stockholders Equity Q3 2023 · Mar 31, 2023 $101.66M
Stockholders Equity Q3 2023 · Dec 31, 2022 $98.26M
Stockholders Equity Q3 2023 · Sep 30, 2022 $123.7M
Stockholders Equity Q3 2023 · Jun 30, 2022 $146.27M
Stockholders Equity Q3 2023 · Mar 31, 2022 $175.65M
Stockholders Equity Q3 2023 · Dec 31, 2021 $209.95M
Current Liabilities Q3 2023 · Sep 30, 2023 $49.38M
Current Liabilities Q3 2023 · Dec 31, 2022 $60.57M
Total Liabilities Q3 2023 · Sep 30, 2023 $122.01M
Total Liabilities Q3 2023 · Dec 31, 2022 $120.64M
Current Assets Q3 2023 · Sep 30, 2023 $153.92M
Current Assets Q3 2023 · Dec 31, 2022 $168.15M
Total Assets Q3 2023 · Sep 30, 2023 $202.27M
Total Assets Q3 2023 · Dec 31, 2022 $218.91M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.15
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.35
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.37
Eps Diluted Q3 2023 · Sep 30, 2022 −$1.12
Eps Basic Q3 2023 · Sep 30, 2023 −$0.15
Eps Basic Q3 2023 · Sep 30, 2023 −$0.35
Eps Basic Q3 2023 · Sep 30, 2022 −$0.37
Eps Basic Q3 2023 · Sep 30, 2022 −$1.12
Sga Expense Q3 2023 · Sep 30, 2023 $11.61M
Sga Expense Q3 2023 · Sep 30, 2023 $33.74M
Sga Expense Q3 2023 · Sep 30, 2022 $11.5M
Sga Expense Q3 2023 · Sep 30, 2022 $38.53M
Rd Expense Q3 2023 · Sep 30, 2023 $14.55M
Rd Expense Q3 2023 · Sep 30, 2023 $47.24M
Rd Expense Q3 2023 · Sep 30, 2022 $18.1M
Rd Expense Q3 2023 · Sep 30, 2022 $68.3M
Net Income Q3 2023 · Sep 30, 2023 −$35.32M
Net Income Q3 2023 · Sep 30, 2023 −$65.04M
Net Income Q3 2023 · Jun 30, 2023 −$12.31M
Net Income Q3 2023 · Mar 31, 2023 −$17.41M
Net Income Q3 2023 · Sep 30, 2022 −$47.57M
Net Income Q3 2023 · Sep 30, 2022 −$142.78M
Net Income Q3 2023 · Jun 30, 2022 −$50.92M
Net Income Q3 2023 · Mar 31, 2022 −$44.3M
Operating Income Q3 2023 · Sep 30, 2023 −$21.61M
Operating Income Q3 2023 · Sep 30, 2023 −$70.43M
Operating Income Q3 2023 · Sep 30, 2022 −$25.47M
Operating Income Q3 2023 · Sep 30, 2022 −$95.5M
Cost Of Revenue Q3 2023 · Sep 30, 2023 $1.75M
Cost Of Revenue Q3 2023 · Sep 30, 2023 $4.3M
Cost Of Revenue Q3 2023 · Sep 30, 2022 $1.65M
Cost Of Revenue Q3 2023 · Sep 30, 2022 $4.34M
Revenue Q3 2023 · Sep 30, 2023 $6.3M
Revenue Q3 2023 · Sep 30, 2023 $14.85M
Revenue Q3 2023 · Sep 30, 2022 $5.78M
Revenue Q3 2023 · Sep 30, 2022 $15.67M